Basic Information
Neurocentria is a late-stage pharmaceutical company dedicated to discovering and developing new therapies for neurodegenerative and neuropsychiatric disorders, including ADHD, depression, and Alzheimer's disease.
Neurocentria, Inc.
California,United States of America
less than 15 people
January 01, 2005
info@neurocentria.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios